Create Alert
Watchlist

Alembic Pharmaceuticals

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹18,420Cr
ROE11.24%
P/E Ratio(TTM)30.54
EPS(TTM)30.68
P/B Ratio3.55
Dividend Yield1.17%
Industry P/E34.34
Book Value264.09
Debt to Equity0.24
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others. ;
Parent OrganisationAlembic Pharmaceuticals
Managing DirectorShri. Pranav Amin
NSE SymbolAPLLTD

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
69.67%
Retail And Others
9.90%
Mutual Funds
9.05%
Other Domestic Institutions
7.41%
Foreign Institutions
3.96%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
36.87
Cipla
NA
(0.00%)
23.81
Dr Reddy's Laboratories
NA
(0.00%)
18.55
Mankind Pharma
NA
(0.00%)
53.89